• Publications
  • Influence
TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.
Androgen receptor (AR) signaling is a key driver of prostate cancer (PC). While androgen-deprivation therapy is transiently effective in advanced disease, tumors often progress to a lethalExpand
  • 120
  • 4
ARv7 Represses Tumor-Suppressor Genes in Castration-Resistant Prostate Cancer.
Androgen deprivation therapy for prostate cancer (PCa) benefits patients with early disease, but becomes ineffective as PCa progresses to a castration-resistant state (CRPC). Initially CRPC remainsExpand
  • 51
  • 3
The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors
BackgroundTo date, all studies conducted on breast cancer diagnosis have focused on the expression of the full-length 66-kDa estrogen receptor alpha (ERα66). However, much less attention has beenExpand
  • 27
  • 3
The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide
Treatment-induced mutations in the ligand-binding domain of the androgen receptor (AR) are known to change antagonists into agonists. Recently, the F877L mutation has been described to convertExpand
  • 37
  • 2
Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer.
Mutations in estrogen receptor alpha (ERα) that confer resistance to existing classes of endocrine therapies are detected in up to 30% of patients who have relapsed during endocrine treatments.Expand
  • 20
  • 2
Quantitative assessment of a novel flow-through porous microarray for the rapid analysis of gene expression profiles.
A novel microarray system that utilizes a porous aluminum-oxide substrate and flow-through incubation has been developed for rapid molecular biological testing. To assess its utility in geneExpand
  • 49
  • 1
Serine-305 Phosphorylation Modulates Estrogen Receptor Alpha Binding to a Coregulator Peptide Array, with Potential Application in Predicting Responses to Tamoxifen
With current techniques, it remains a challenge to assess coregulator binding of nuclear receptors, for example, the estrogen receptor alpha (ERα). ERα is critical in many breast tumors and isExpand
  • 39
  • 1
  • PDF
A 155-plex high-throughput in vitro coregulator binding assay for (anti-)estrogenicity testing evaluated with 23 reference compounds.
To further develop an integrated in vitro testing strategy for replacement of in vivo tests for (anti-)estrogenicity testing, the ligand-modulated interaction of coregulators with estrogen receptor αExpand
  • 25
  • 1
  • PDF
Cell proliferation and modulation of interaction of estrogen receptors with coregulators induced by ERα and ERβ agonists
The aim of the present study was to investigate modulation of the interaction of the ERα and ERβ with coregulators in the ligand responses induced by estrogenic compounds. To this end, selective ERαExpand
  • 12
  • 1